Currently out of the existing stock ratings of Olivia Brayer, 76 are a BUY (62.3%), 46 are a HOLD (37.7%).

Olivia Brayer

Work Performance Price Targets & Ratings Chart

Analyst Olivia Brayer, currently employed at BAIRD, carries an average stock price target met ratio of 59.43% that have a potential upside of 32.94% achieved within 128 days. Previously, Olivia Brayer worked at CANTOR FITZGERALD, BAML.

Olivia Brayer’s has documented 238 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GOSS, Gossamer Bio at 23-Mar-2026.

Wall Street Analyst Olivia Brayer

Analyst best performing recommendations are on UTHR (UNITED THERAPEUTICS).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/22/2024. The price target of $45 was fulfilled within 4 days with a profit of $6.11 (15.71%) receiving and performance score of 39.28.

Average potential price target upside

ALNY Alnylam Pharmaceuticals AMGN Amgen AUPH Aurinia Pharmaceuticals BMRN Biomarin Pharmaceutical BMY Bristol-Myers Squibb Company CTMX CytomX Therapeutics GILD Gilead Sciences GRPH Graphite Bio MNKD MannKind Corp REGN Regeneron Pharmaceuticals UTHR United Therapeutics VNDA Vanda Pharmaceuticals VRNA Verona Pharma PLC ADR VRTX Vertex Pharmaceuticals GOSS Gossamer Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-May-2025

$369

$149.28 (67.94%)

$375

Buy Since 12-Feb-2021

$455

$235.28 (107.08%)

$455

12 days ago
(21-Sep-2026)

23/41 (56.1%)

$210.68 (86.23%)

688

Hold Since 08-Sep-2026

$260

$40.28 (18.33%)

$330

25 days ago
(08-Sep-2026)

2/2 (100%)

$-0.1 (-0.04%)

8

Buy Since 21-Mar-2025

$318

$98.28 (44.73%)

$583

1 months 14 days ago
(19-Aug-2026)

34/36 (94.44%)

$75.39 (31.07%)

263

Hold Since 20-Oct-2025

$256

$36.28 (16.51%)

$316

1 months 19 days ago
(14-Aug-2026)

2/6 (33.33%)

$27.35 (11.96%)

38

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Olivia Brayer?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?